Condition
NCT_id
Keyword
Search:
0.
1. 10-226
2. 15.21.gpc3-car t cells
3. 15.gpc3-car t cells
4. 17 aag
5. 17-654
6. 18-254
7. 19-195
8. 1p36 deletion syndrome
9. 3-dioxygenase 1 (ido1) inhibitor
10. 4p-/wolf-hirschhorn syndrome
11. abdomen
12. abdominal wash
13. abemaciclib
14. ablation
15. accelerated phase chronic myelogenous leukemia
16. accelerated phase cml
17. acute lymphoblastic leukemia
18. acute myeloid leukemia
19. acute undifferentiated leukemia
20. adc
21. adegramotide
22. adenocarcinoma of the bladder
23. adenocarcinoma of the colon
24. adenocarcinoma of the esophagus
25. adenocarcinoma of the extrahepatic bile duct
26. adenocarcinoma of the gallbladder
27. adenocarcinoma of the lung
28. adenocarcinoma of the pancreas
29. adenocarcinoma of the prostate
30. adenocarcinoma of the rectum
31. adenocarcinoma of the stomach
32. adenocarcinoma of unknown primary
33. adenocarcinoma with squamous metaplasia of the gallbladder
34. adjuvant
35. adrenocortical carcinoma (acc)
36. adrenocortical carcinoma;
37. adrenocorticocarcinoma
38. adult acute lymphoblastic leukemia in remission
39. adult acute myeloid leukemia in remission
40. adult acute myeloid leukemia with 11q23 (mll) abnormalities
41. adult acute myeloid leukemia with inv(16)(p13;q22)
42. adult acute myeloid leukemia with t(15;17)(q22;q12)
43. adult acute myeloid leukemia with t(16;16)(p13;q22)
44. adult acute myeloid leukemia with t(8;21)(q22;q22)
45. adult all in remission
46. adult aml with 11q23 (mll) abnormalities
47. adult aml with inv(16)(p13;q22)
48. adult aml with t(15;17)(q22;q12)
49. adult aml with t(16;16)(p13;q22)
50. adult aml with t(8;21)(q22;q22)
51. adult anaplastic astrocytoma
52. adult anaplastic ependymoma
53. adult anaplastic meningioma
54. adult anaplastic oligodendroglioma
55. adult angiosarcoma
56. adult astrocytic tumors
57. adult brain stem glioma
58. adult brain tumor
59. adult central nervous system germ cell tumor
60. adult choroid plexus tumor
61. adult cml in remission
62. adult craniopharyngioma
63. adult diffuse astrocytoma
64. adult embryonal tumor
65. adult ependymal tumors
66. adult ependymoblastoma
67. adult ependymoma
68. adult fibrosarcoma
69. adult giant cell glioblastoma
70. adult glioblastoma
71. adult gliosarcoma
72. adult grade i meningioma
73. adult grade ii meningioma
74. adult grade iii lymphomatoid granulomatosis
75. adult grade iii meningioma
76. adult hodgkin lymphoma
77. adult leiomyosarcoma
78. adult liposarcoma
79. adult malignant fibrous histiocytoma
80. adult malignant hemangiopericytoma
81. adult malignant mesenchymoma
82. adult medulloblastoma
83. adult meningeal hemangiopericytoma
84. adult meningeal tumor
85. adult meningioma
86. adult mixed glioma
87. adult myxopapillary ependymoma
88. adult nasal type extranodal nk/t-cell lymphoma
89. adult neurofibrosarcoma
90. adult non-hodgkin lymphoma
91. adult oligodendroglial tumors
92. adult oligodendroglioma
93. adult papillary meningioma
94. adult pilocytic astrocytoma
95. adult pineal gland astrocytoma
96. adult pineal parenchymal tumor
97. adult pineoblastoma
98. adult pineocytoma
99. adult primary liver cancer
100. adult rhabdomyosarcoma
101. adult solid tumor
102. adult subependymal giant cell astrocytoma
103. adult subependymoma
104. adult supratentorial primitive neuroectodermal tumor (pnet)
105. adult synovial sarcoma
106. adult t-cell leukemia/lymphoma
107. adult teratoma
108. adults
109. advanced
110. advanced adult primary liver cancer
111. advanced kidney cancer
112. advanced malignant mesothelioma
113. advanced metastatic pediatric solid tumors
114. advanced non-clear cell renal cell cancer (rcc)
115. advanced rcc
116. advanced renal cancer
117. advanced renal cell carcinoma
118. advanced solid tumors
119. advanced transitional cell carcinoma
120. advanced uc
121. advanced urothelial carcinoma
122. advanced/metastatic
123. afinitor
124. africa
125. agnostic
126. ags-16c3f
127. ags-16m18
128. ags-16m8f
129. aids-related kaposi sarcoma
130. aids-related lymphoma
131. aids-related peripheral/systemic lymphoma
132. aids-related primary cns lymphoma
133. alagille syndrome
134. alimta
135. alk
136. alk fusions
137. alk gene rearrangements
138. alk mutation
139. alk positive
140. alk+
141. alk+ solid tumors
142. alk-positive
143. all
144. allogeneic hematopoietic stem cell transplant
145. alveolar childhood rhabdomyosarcoma
146. alveolar rhabdomyosarcoma
147. alveolar soft part sarcoma
148. alveolar soft part sarcoma (asps)
149. aml/transient myeloproliferative disorder
150. anal cancer
151. anaplastic large cell lymphoma
152. anaplastic lymphoma kinase positive
153. anaplastic osteosarcoma
154. anaplastic thyroid cancer
155. anemia
156. angiogenesis
157. angiogenesis;
158. angioimmunoblastic t-cell lymphoma
159. aniridia
160. anterior urethral cancer
161. anthracyclines
162. anti pd-l1
163. anti-angiogenesis
164. anti-pdl1
165. anti-vegf monoclonal antibody
166. antiangiogenics
167. antibody
168. antitumor activity
169. askin tumor
170. ataxia
171. ataxia telangiectasia
172. atezolizumab
173. atypical chronic myeloid leukemia
174. atypical chronic myeloid leukemia; bcr-abl negative
175. atypical chronic myeloid leukemia; bcr-abl1 negative
176. atypical cml; bcr-abl negative
177. atypical hemolytic uremic syndrome
178. atypical teratoid/rhabdoid tumor
179. autoimmune/inflammatory syndrome induced by adjuvants (asia)
180. autologous stem cell transplantation
181. autologous transplantation
182. av-951
183. avastin
184. avelumab
185. axitinib
186. azd6094
187. b-cell childhood acute lymphoblastic leukemia
188. basal cell skin cancer
189. basket study
190. batten disease
191. bay 43-9006
192. beckwith-wiedemann hemihypertrophy
193. behavior and neurocognition
194. behcet's disease
195. bellini
196. bempeg
197. bempegaldesleukin
198. bevacizumab
199. bhd
200. bile duct cancer
201. biomarker
202. biomarkers
203. birt hogg dube (bhd)
204. bladder
205. bladder cancer
206. bladder/urachal adenocarcinoma
207. blastema predominant wilms tumor
208. blastic phase chronic myelogenous leukemia
209. blastic phase cml
210. bms-936558
211. bms-986298
212. bnc105p
213. body mass index
214. body system/site cancer
215. bone cancer
216. bone metastases
217. bone sarcomas
218. borderline ovarian surface epithelial-stromal tumor
219. botox therapy
220. brain
221. brain stem glioma
222. brain tumor
223. brain tumors
224. breast
225. breast cancer
226. breast cancer in situ
227. breast implant-associated anaplastic large cell lymphoma
228. burkitt lymphoma
229. c-met
230. cabozantinib
231. cachexia
232. cancer
233. cancer risk
234. cancer survivor
235. cancer vaccine
236. capecitabine
237. car t cell
238. carcinoma
239. carcinoma of the appendix
240. carcinoma; advanced renal cell
241. carcinoma; renal cell
242. cardiotoxicity
243. castrate-resistant prostate cancer (crpc)
244. castration-resistant
245. catheter ablation
246. ccrcc
247. cd122
248. cd122-biased agonist
249. cd122-biased cytokine
250. cd122-preferential
251. cd133 cell selection
252. cdc
253. cddp
254. cdh6
255. cell
256. celldex
257. central nervous system cancer
258. central nervous system neoplasm
259. cerebellar astrocytoma
260. cerebral astrocytoma
261. cervical adenocarcinoma
262. cervical cancer
263. checkpoint inhibition
264. checkpoint inhibitor
265. chemotherapy
266. chemotherapy side-effects
267. childhood acute basophilic leukemia
268. childhood acute eosinophilic leukemia
269. childhood acute erythroleukemia (m6)
270. childhood acute lymphoblastic leukemia
271. childhood acute lymphoblastic leukemia in remission
272. childhood acute megakaryocytic leukemia (m7)
273. childhood acute monoblastic leukemia (m5a)
274. childhood acute monocytic leukemia (m5b)
275. childhood acute myeloid leukemia in remission
276. childhood acute myeloid leukemia/other myeloid malignancies
277. childhood acute myelomonocytic leukemia (m4)
278. childhood acute promyelocytic leukemia (m3)
279. childhood alveolar soft-part sarcoma
280. childhood angiosarcoma
281. childhood atypical teratoid/rhabdoid tumor
282. childhood brain stem glioma
283. childhood brain tumor
284. childhood burkitt lymphoma
285. childhood cancer
286. childhood central nervous system choriocarcinoma
287. childhood central nervous system embryonal tumor
288. childhood central nervous system germ cell tumor
289. childhood central nervous system germinoma
290. childhood central nervous system mixed germ cell tumor
291. childhood central nervous system teratoma
292. childhood central nervous system yolk sac tumor
293. childhood cerebellar astrocytoma
294. childhood cerebral astrocytoma
295. childhood cerebral astrocytoma/malignant glioma
296. childhood choroid plexus tumor
297. childhood chronic myelogenous leukemia
298. childhood craniopharyngioma
299. childhood desmoplastic small round cell tumor
300. childhood diffuse large cell lymphoma
301. childhood ependymoblastoma
302. childhood ependymoma
303. childhood epithelioid sarcoma
304. childhood extracranial germ cell tumor
305. childhood extragonadal germ cell tumor
306. childhood extragonadal malignant germ cell tumor
307. childhood fibrosarcoma
308. childhood germ cell tumor
309. childhood gliosarcoma
310. childhood gonadal germ cell tumor
311. childhood grade i meningioma
312. childhood grade ii meningioma
313. childhood grade iii lymphomatoid granulomatosis
314. childhood grade iii meningioma
315. childhood hepatoblastoma
316. childhood high-grade cerebellar astrocytoma
317. childhood high-grade cerebral astrocytoma
318. childhood hodgkin lymphoma
319. childhood immunoblastic large cell lymphoma
320. childhood infratentorial ependymoma
321. childhood kidney tumors
322. childhood langerhans cell histiocytosis
323. childhood large cell lymphoma
324. childhood leiomyosarcoma
325. childhood liposarcoma
326. childhood liver cancer
327. childhood low-grade cerebellar astrocytoma
328. childhood low-grade cerebral astrocytoma
329. childhood lymphoblastic lymphoma
330. childhood malignant ovarian germ cell tumor
331. childhood malignant testicular germ cell tumor
332. childhood mature and immature teratomas
333. childhood medulloblastoma
334. childhood medulloepithelioma
335. childhood meningioma
336. childhood mixed glioma
337. childhood myelodysplastic syndromes
338. childhood nasal type extranodal nk/t-cell lymphoma
339. childhood neurofibrosarcoma
340. childhood oligodendroglioma
341. childhood pineal parenchymal tumor
342. childhood renal cell carcinoma
343. childhood rhabdomyosarcoma
344. childhood small noncleaved cell lymphoma
345. childhood soft tissue sarcoma
346. childhood solid tumor
347. childhood spinal cord neoplasm
348. childhood supratentorial ependymoma
349. childhood supratentorial primitive neuroectodermal and pineal tumors
350. childhood supratentorial primitive neuroectodermal tumor
351. childhood synovial sarcoma
352. childhood teratoma
353. childhood visual pathway and hypothalamic glioma
354. children
355. cholangiocarcinoma
356. chondrosarcoma
357. chondrosarcomatous osteosarcoma
358. chordoma
359. chordoma (poorly differentiated or de-differentiated)
360. chpp
361. chromophobe
362. chromophobe renal cell
363. chromophobe renal cell carcinoma
364. chronic eosinophilic leukemia
365. chronic idiopathic myelofibrosis
366. chronic myelogenous leukemia
367. chronic myelogenous leukemia; bcr-abl1 positive
368. chronic myeloid leukemia
369. chronic myelomonocytic leukemia
370. chronic neutrophilic leukemia
371. chronic phase chronic myelogenous leukemia
372. chronic phase cml
373. chronic recurrent multifocal osteomyelitis (crmo)
374. ciliary body and choroid melanoma; medium/large size
375. ciliary body and choroid melanoma; small size
376. cisplatin
377. classic kaposi sarcoma
378. clear cell
379. clear cell renal cancer
380. clear cell renal carcinoma
381. clear cell renal cell carcinoma
382. clear cell sarcoma
383. clear cell sarcoma (ccs)
384. clear cell sarcoma of the kidney
385. clear-cell renal cell carcinoma
386. clinical trial; phase 1
387. clinimacs device
388. cns hemangioblastoma
389. cockayne syndrome
390. collected duct carcinoma
391. collecting duct
392. collecting duct carcinoma
393. collecting duct renal cell carcinoma
394. colorectal cancer
395. colorectal cancer (crc)
396. comfort care
397. congenital mesoblastic nephroma
398. contiguous st ii adult diffuse small cleaved cell lymphoma
399. contiguous stage ii adult burkitt lymphoma
400. contiguous stage ii adult diffuse large cell lymphoma
401. contiguous stage ii adult diffuse mixed cell lymphoma
402. contiguous stage ii adult diffuse small cleaved cell lymphoma
403. contiguous stage ii adult immunoblastic large cell lymphoma
404. contiguous stage ii adult lymphoblastic lymphoma
405. contiguous stage ii grade 1 follicular lymphoma
406. contiguous stage ii grade 2 follicular lymphoma
407. contiguous stage ii grade 3 follicular lymphoma
408. contiguous stage ii mantle cell lymphoma
409. contiguous stage ii marginal zone lymphoma
410. contiguous stage ii small lymphocytic lymphoma
411. continuous hyperthermic peritoneal perfusion
412. cornelia de lange syndrome
413. crizotinib
414. ct-guided
415. cutaneous leiomyoma
416. cutaneous leiomyomas
417. cutaneous lymphoma
418. cystic nephroma
419. cysts
420. cytomegalovirus infection
421. dd
422. de novo mds
423. de novo myelodysplastic syndromes
424. deafness
425. denys-drash syndrome
426. desmoid tumor
427. desmoplastic round cell tumor
428. desmoplastic small round cell tumor
429. dff332
430. dicer1
431. differentiation
432. diffuse adenocarcinoma of the stomach
433. disseminated neuroblastoma
434. distal urethral cancer
435. dna
436. dna hypermethylation
437. dna methyltransferase (dnmt) inhibitor
438. dose escalation
439. dose-escalation
440. doxil
441. doxorubicin
442. drug resistance
443. dsp-7888
444. duct cell adenocarcinoma of the pancreas
445. duet-2
446. durvalumab
447. dwi
448. efficacy
449. egfr inhibitor
450. electromagnetic tracking
451. embryonal brain tumor
452. embryonal childhood rhabdomyosarcoma
453. embryonal-botryoid childhood rhabdomyosarcoma
454. endocrine cancer
455. endometrial
456. endometrial adenocarcinoma
457. endometrial stromal sarcoma
458. endothelium
459. energy homeostasis
460. entrectinib
461. ependymoma
462. epithelial ovarian cancer
463. epithelial predominant wilms tumor
464. epithelioid sarcoma
465. epothilone
466. epothilone b
467. esk981
468. esophageal cancer
469. espn
470. essential thrombocythemia
471. everolimus
472. ewing
473. ewing family of tumors
474. ewing sarcoma
475. ewing sarcoma family of tumors
476. ewing sarcoma/peripheral primitive neuroectodermal tumor (pnet)
477. ewing's family of tumors
478. ewing's sarcoma
479. ewing's sarcoma metastatic
480. ewing's tumor metastatic
481. ex vivo drug sensitivity assay
482. experimental
483. expression of jagged 1 and 2
484. extensive stage small cell lung cancer
485. extragonadal germ cell tumor
486. extramedullary plasmacytoma
487. extranodal marginal zone b-cell lymphoma of mucosa tissue
488. extranodal marginal zone b-cell lymphoma of mucosa-associated lymphoid tissue
489. extraocular extension melanoma
490. extraocular retinoblastoma
491. extraosseous ewing sarcoma
492. fallopian tube cancer
493. familial cancer
494. fatigue
495. female reproductive
496. fever; sweats; and hot flashes
497. fibrofolliculoma
498. fibrosarcomatous osteosarcoma
499. first in human
500. folate-hapten conjugate
501. follicular lymphoma
502. ftc
503. galinpepimut-s
504. gastric and gastroesophageal junction (gej) cancer
505. gastric cancer
506. gastrinoma
507. gastroesophageal junction cancer
508. gastrointestinal adenocarcinoma
509. gastrointestinal cancer
510. gastrointestinal stromal tumor
511. gastrointestinal stromal tumors
512. gc
513. gemcitabine
514. gemcitabine hydrochloride
515. gemzar
516. gene expression
517. gene-environment interaction
518. genes
519. genetic condition
520. genetic counseling
521. genetic epidemiology
522. genetic modifiers
523. genetic predisposition
524. genistein
525. genitourinary
526. genitourinary anomalies
527. genome analysis
528. genomic profiling
529. genotype/phenotype correlation
530. germ cell tumors
531. gi
532. girentuximab
533. glioma
534. glioma includes ependymoma and medulloblastoma
535. glucagonoma
536. glypican
537. gpc3
538. grade
539. graft versus host disease
540. gw786034
541. hc-5404
542. hc-5404-fu
543. head & neck cancers
544. head and neck cancer
545. head and neck squamous cell carcinoma (hnscc)
546. healthy volunteer
547. hemangioblastoma
548. hematologic malignancies
549. hemophagocytic lymphohistiocytosis (hlh)
550. hepatic tumor
551. hepatic tumors
552. hepatoblastoma
553. hepatocellular cancer
554. hepatocellular carcinoma
555. hepatocyte growth factor receptor protein (met)
556. hereditary cancer syndrome
557. hereditary leiomyomatosis
558. hereditary leiomyomatosis and renal cell cancer
559. hereditary leiomyomatosis and renal cell cancer syndrome
560. hereditary leiomyomatosis and renal cell carcinoma (hlrcc)
561. hereditary papillary renal cancer (hprc)
562. hereditary papillary renal cell carcinoma
563. hereditary papillary renal cell carcinoma;
564. hereditary sensory and autonomic neuropathy
565. hereditary wilms tumor
566. heritable disease
567. hgsoc
568. high intensity focused ultrasound
569. high risk
570. high risk metastatic gestational trophoblastic tumor
571. high risk of relapse/recurrence
572. high risk solid tumor
573. high-grade neuroendocrine cancer
574. high-grade salivary gland mucoepidermoid carcinoma
575. high-grade serous epithelial ovarian cancer
576. hiv infections
577. hkt288
578. hlrcc
579. hodgkin lymphoma
580. hyperacusis
581. hypersomnia
582. hyperthermic perfusion
583. hypophosphatasia
584. hypothalamic glioma
585. hypoxia inducible factor (hif)
586. hypoxia inducible factor 2 alpha (hif-2α)
587. ice
588. ici
589. il-2
590. il-2 pathway agonist
591. il-2 receptor agonist
592. il-27
593. imagery
594. imaging
595. immune checkpoint inhibitor
596. immuno-oncology
597. immuno-oncology therapy
598. immunosuppressive treatment related kaposi sarcoma
599. immunotherapy
600. inclusion body myopathy with early-onset paget disease and frontotemporal dementia (ibmpfd)
601. indocyanine green
602. indoleamine 2
603. infection
604. inflammatory breast cancer
605. inflammatory myofibroblastic tumor
606. ini1 negative tumors
607. inlyta
608. inner ear
609. insular thyroid cancer
610. insulinoma
611. intestinal adenocarcinoma of the stomach
612. intraocular lymphoma
613. intraocular melanoma
614. intraocular retinoblastoma
615. intravenous
616. irinotecan
617. iris melanoma
618. isoflavone
619. isolated plasmacytoma of bone
620. ixabepilone
621. jansen metaphyseal chondrodysplasia
622. juvenile myelomonocytic leukemia
623. kabuki syndrome
624. kawasaki disease
625. keytruda
626. kidney
627. kidney cancer
628. kidney diseases
629. kidney failure; chronic
630. kidney neoplasms
631. kidney tumor
632. kidney tumors
633. kidney/urinary cancer
634. kleine-levin syndrome
635. klippel-feil syndrome
636. l1 childhood acute lymphoblastic leukemia
637. l2 childhood acute lymphoblastic leukemia
638. l3 childhood acute lymphoblastic leukemia
639. lactoferrin
640. leiomyosarcoma
641. lenvatinib
642. leptomeningeal metastases
643. leukemia
644. limited stage small cell lung cancer
645. liquid biopsy
646. liver
647. liver and intrahepatic biliary tract cancer
648. liver cancer
649. liver metastases
650. localized
651. localized benign pheochromocytoma
652. localized ewing sarcoma
653. localized ewing sarcoma/peripheral primitive neuroectodermal tumor
654. localized ewing sarcoma/pnet
655. localized extrahepatic bile duct cancer
656. localized gallbladder cancer
657. localized gastrointestinal carcinoid tumor
658. localized malignant mesothelioma
659. localized osteosarcoma
660. localized resectable adult primary liver cancer
661. localized resectable neuroblastoma
662. localized transitional cell cancer of the renal pelvis and ureter
663. localized unresectable adult primary liver cancer
664. localized unresectable neuroblastoma
665. locally
666. locally advanced or metastatic
667. locally advanced or metastatic non-clear cell renal cell cancer (ncc-rcc)
668. locally advanced or metastatic renal cell carcinoma
669. low-grade salivary gland mucoepidermoid carcinoma
670. lowe syndrome
671. lung
672. lung cancer
673. lung cancer; renal cancer; bladder cancer; skin cancer; liver cancer
674. lung metastases
675. lung metastasis
676. lung metastasis in children
677. lung papilloma
678. ly231514
679. lymph node involvement
680. lymphoblastic leukemia
681. lymphoblastic lymphoma
682. lymphoma
683. lyso-thermosensitive liposomal doxorubicin
684. m3thodist
685. malan syndrome
686. male breast cancer
687. malignant adnexal tumor
688. malignant germ cell tumor
689. malignant giant cell tumor of bone
690. malignant neoplasms of urinary tract
691. malignant ovarian germ cell tumor
692. malignant pericardial effusion
693. malignant peripheral nerve sheath tumors
694. malignant pleural effusion
695. malignant rhabdoid tumor
696. malignant testicular germ cell tumor
697. mantle cell lymphoma
698. marginal zone lymphoma
699. marinesco-sjogren syndrome
700. mast cell leukemia
701. mast cell sarcoma
702. maximum tolerated dose
703. maytansine
704. mca
705. mds/myeloproliferative neoplasm; unclassifiable
706. medullary
707. medullary renal cell carcinoma
708. medulloblastoma
709. melanoma
710. memorial sloan kettering cancer center
711. meningeal chronic myelogenous leukemia
712. meningeal melanocytoma
713. mental retardation
714. mesothelioma
715. met driven
716. metastatic
717. metastatic adult malignant fibrous histiocytoma of bone
718. metastatic breast cancer (mbc)
719. metastatic carcinoma
720. metastatic childhood malignant fibrous histiocytoma of bone
721. metastatic childhood soft tissue sarcoma
722. metastatic ewing sarcoma
723. metastatic ewing sarcoma/peripheral primitive neuroectodermal tumor
724. metastatic ewing sarcoma/pnet
725. metastatic gastrointestinal carcinoid tumor
726. metastatic kidney cancer
727. metastatic malignant melanoma
728. metastatic ncc renal cell carcinoma
729. metastatic osteosarcoma
730. metastatic parathyroid cancer
731. metastatic pheochromocytoma
732. metastatic rcc
733. metastatic recurrent renal cell carcinoma
734. metastatic renal cancer
735. metastatic renal cell cancer
736. metastatic renal cell carcinoma
737. metastatic solid tumors
738. metastatic squamous neck cancer with occult primary
739. metastatic squamous neck cancer with occult primary squamous cell carcinoma
740. metastatic transitional cell cancer of the renal pelvis and ureter
741. metastatic transitional cell carcinoma
742. metastatic uc
743. metastatic unresectable renal cell carcinoma
744. metastatic urothelial carcinoma
745. metastatic; bone metastases
746. metastatic; non-clear cell; renal cell carcinoma
747. microphthalmia transcription (mit) factor associated tumors
748. minimal access surgery
749. minimal residual disease
750. minimally differentiated myeloid leukemia (m0)
751. mirna
752. mixed adenocarcinoma of the stomach
753. mixed cell type wilms tumor
754. mixed childhood rhabdomyosarcoma
755. mixed osteosarcoma
756. molecular imaging
757. molecular target
758. monoclonal gammopathy of undetermined significance
759. montanide
760. mrcc
761. mri
762. msb0010718c
763. msi-high colorectal cancer
764. msi-high endometrial cancer
765. mta
766. mtor inhibitor
767. mtor pathway;
768. mtor therapy naive
769. mucinous adenocarcinoma of the colon
770. mucinous adenocarcinoma of the rectum
771. mucolipidosis iv
772. mucositis
773. mulitparametric mr imaging
774. multi-arm multi-stage
775. multidrug resistance reversal
776. multiple endocrine neoplasia
777. multitargeted antifolate
778. muscle cancer
779. musculoskeletal cancer
780. mwa
781. myeloblastic leukemia with maturation (m2)
782. myeloblastic leukemia without maturation (m1)
783. myelodysplastic syndromes
784. myelodysplastic/myeloproliferative disease; unclassifiable
785. myelodysplastic/myeloproliferative neoplasm; unclassifiable
786. myvhl
787. n-myc expression
788. narcolepsy
789. nasopharyngeal cancer
790. natriuretic peptide
791. nausea and vomiting
792. nc stage ii adult diffuse large cell lymphoma
793. nc stage ii adult diffuse mixed cell lymphoma
794. nc stage ii adult diffuse small cleaved cell lymphoma
795. nc stage ii adult immunoblastic large cell lymphoma
796. nc stage ii adult lymphoblastic lymphoma
797. nc stage ii grade 1 follicular lymphoma
798. nc stage ii grade 2 follicular lymphoma
799. nc stage ii grade 3 follicular lymphoma
800. nc stage ii mantle cell lymphoma
801. nc stage ii marginal zone lymphoma
802. nc stage ii small lymphocytic lymphoma
803. near infra-red fluoroscopy
804. neglected diseases
805. nelatimotide
806. neoadjuvant
807. neoantigen
808. neoplasm
809. neoplasms
810. nephrectomy
811. nephroblastoma
812. nephrotic syndrome
813. neuroblastoma
814. neuroectodermal tumor
815. neuroendocrine
816. neurotoxicity
817. neutropenia
818. newly diagnosed carcinoma of unknown primary
819. newly diagnosed childhood ependymoma
820. nexavar
821. next generation sequencing
822. next generation sequencing (ngs)
823. nir178
824. nivolumab
825. nktr-214
826. nociception
827. nodal marginal zone b-cell lymphoma
828. non clear cell carcinoma
829. non-clear cell
830. non-clear cell histology
831. non-clear cell renal carcinoma
832. non-clear cell renal cell cancer
833. non-clear cell renal cell carcinoma
834. non-cns solid tumor
835. non-hodgkin lymphoma during pregnancy
836. non-progression
837. non-rhabdomyosarcoma soft tissue sarcomas
838. non-small cell lung cancer
839. non-small cell lung cancer (nsclc)
840. non-t; non-b; calla negative childhood acute lymphoblastic leukemia
841. non-t; non-b; calla positive childhood acute lymphoblastic leukemia
842. non-t; non-b; calla positive; pre-b childhood acute lymphoblastic leukemia
843. nonclear cell
844. noncontiguous (nc) stage ii adult burkitt lymphoma
845. noncontiguous st ii diffuse small cleaved cell lymphoma
846. noncontiguous stage ii adult burkitt lymphoma
847. noncontiguous stage ii adult diffuse large cell lymphoma
848. noncontiguous stage ii adult diffuse mixed cell lymphoma
849. noncontiguous stage ii adult diffuse small cleaved cell lymphoma
850. noncontiguous stage ii adult immunoblastic large cell lymphoma
851. noncontiguous stage ii adult lymphoblastic lymphoma
852. noncontiguous stage ii grade 1 follicular lymphoma
853. noncontiguous stage ii grade 2 follicular lymphoma
854. noncontiguous stage ii grade 3 follicular lymphoma
855. noncontiguous stage ii mantle cell lymphoma
856. noncontiguous stage ii marginal zone lymphoma
857. noncontiguous stage ii small lymphocytic lymphoma
858. noncutaneous extranodal lymphoma
859. nonmetastatic childhood soft tissue sarcoma
860. notch signaling pathway
861. nsc-698037
862. obesity
863. occult non-small cell lung cancer
864. odsh
865. olaparib
866. ombipepimut-s
867. oncology
868. oncolytic virus
869. onivyde
870. opdivo
871. opdivo®
872. oral
873. oral complications
874. orphan diseases
875. osteoblastic osteosarcoma
876. osteosarcoma
877. osteosarcoma in children
878. osteosarcoma/malignant fibrous histiocytoma of bone
879. osteosarcoma; metastatic
880. other myeloid malignancies
881. other tumor of glial origin
882. ovarian
883. ovarian cancer
884. ovarian carcinoma
885. ovarian carcinosarcoma
886. ovarian choriocarcinoma
887. ovarian clear cell cystadenocarcinoma
888. ovarian embryonal carcinoma
889. ovarian endometrioid adenocarcinoma
890. ovarian germ cell
891. ovarian germ cell tumor
892. ovarian immature teratoma
893. ovarian mature teratoma
894. ovarian mixed germ cell tumor
895. ovarian monodermal and highly specialized teratoma
896. ovarian mucinous cystadenocarcinoma
897. ovarian polyembryoma
898. ovarian sarcoma
899. ovarian serous cystadenocarcinoma
900. ovarian stromal cancer
901. ovarian teratoma
902. ovarian undifferentiated adenocarcinoma
903. ovarian yolk sac tumor
904. overall response
905. overall response rate
906. p-glycoprotein inhibition
907. p-glycoprotien
908. paediatric
909. pain
910. palliative care
911. pancreas
912. pancreatic cancer
913. pancreatic polypeptide tumor
914. papillary
915. papillary carcinoma
916. papillary cell renal carcinoma
917. papillary renal cell
918. papillary renal cell cancer
919. papillary renal cell carcinoma
920. papillary renal cell carcinoma type 1
921. papillary renal cell carcinoma(prc)
922. papillary thyroid cancer
923. paraganglioma
924. parp inhibitor
925. partial response [pr] + complete response [cr])
926. patient reported outcomes
927. pazopanib
928. pazopanib(gw786034)
929. pd-1
930. pd-1 inhibitor
931. pd-1inhibitor
932. pd-l1
933. pd-l1 inhibitor
934. pd-l2
935. pd1
936. pdl1
937. pdl2
938. pdr001
939. pediatric
940. pediatric cancer
941. pediatric germ cell tumor
942. pediatric solid tumors
943. pediatrics
944. peg ifn
945. pegylated alfa interferon
946. pembrolizumab
947. pemetrexed
948. penile cancer
949. penile cancers
950. pentostatin
951. peripheral neuropathy
952. peripheral primitive neuroectodermal tumor
953. peripheral primitive neuroectodermal tumor of the kidney
954. peritoneal cancer
955. peritoneal tumor
956. personalized
957. pet/ct
958. pexa-vec
959. pfs;
960. pharmacodynamics
961. pharmacokinetic
962. pharmacokinetics
963. pharmacokinetics of ags-16c3f
964. phase 1
965. phase 2
966. phase i
967. phase ii
968. pheochromocytoma
969. philadelphia chromosome negative chronic myelogenous leukemia
970. philadelphia chromosome positive chronic myelogenous leukemia
971. philadelphia chromosome positive cml
972. phosphaturic mesenchymal tumor
973. pitt hopkins syndrome
974. platelet recovery
975. platinol®
976. platinol®-aq
977. platinum-resistant ovarian cancer
978. pleomorphic childhood rhabdomyosarcoma
979. pleural mesothelioma
980. pleuropulmonary blastoma
981. pneumothorax
982. polycythemia vera
983. poor prognosis metastatic gestational trophoblastic tumor
984. poor vascular access
985. post-transplant lymphoproliferative disorder
986. posterior urethral cancer
987. ppb
988. ppc
989. previously treated childhood rhabdomyosarcoma
990. previously treated mds
991. previously treated myelodysplastic syndromes
992. previously untreated childhood rhabdomyosarcoma
993. primary brain tumors
994. primary central nervous system hodgkin lymphoma
995. primary central nervous system lymphoma
996. primary central nervous system non-hodgkin lymphoma
997. primary myelofibrosis
998. primary peritoneal cancer
999. primary peritoneal cavity cancer
1000. primary systemic amyloidosis
1001. proc
1002. progastrin
1003. programmed cell death 1 (pd-1) inhibitor
1004. programmed cell death-1 (pd1; pd-1)
1005. programmed death-ligand 1 (pdl1; pd-l1)
1006. progressive
1007. progressive hairy cell leukemia; initial treatment
1008. prolactin receptor (prlr)
1009. prolactin-producing pituitary tumor
1010. prolymphocytic leukemia
1011. prophylactic itraconazole
1012. prostate
1013. prostate cancer
1014. proteinuria
1015. proximal urethral cancer
1016. psychosocial effects of cancer and its treatment
1017. pulmonary carcinoid tumor
1018. pulmonary complications
1019. pulmonary metastasis
1020. pulmonary metastasis in children
1021. quantitative estimation
1022. questionnaire
1023. rad001
1024. radiation for children
1025. radiation therapy
1026. randomized controlled trials
1027. rare disease research
1028. rare diseases
1029. rcc
1030. rcc;
1031. recurrent
1032. recurrent adenoid cystic carcinoma of the oral cavity
1033. recurrent adrenocortical carcinoma
1034. recurrent adult acute lymphoblastic leukemia
1035. recurrent adult acute myeloid leukemia
1036. recurrent adult brain tumor
1037. recurrent adult burkitt lymphoma
1038. recurrent adult diffuse large cell lymphoma
1039. recurrent adult diffuse mixed cell lymphoma
1040. recurrent adult diffuse small cleaved cell lymphoma
1041. recurrent adult grade iii lymphomatoid granulomatosis
1042. recurrent adult hodgkin lymphoma
1043. recurrent adult immunoblastic large cell lymphoma
1044. recurrent adult lymphoblastic lymphoma
1045. recurrent adult primary liver cancer
1046. recurrent adult soft tissue sarcoma
1047. recurrent adult t-cell leukemia/lymphoma
1048. recurrent anal cancer
1049. recurrent basal cell carcinoma of the lip
1050. recurrent bladder cancer
1051. recurrent breast cancer
1052. recurrent carcinoma of unknown primary
1053. recurrent cervical cancer
1054. recurrent childhood acute lymphoblastic leukemia
1055. recurrent childhood acute myeloid leukemia
1056. recurrent childhood anaplastic astrocytoma
1057. recurrent childhood anaplastic large cell lymphoma
1058. recurrent childhood anaplastic oligoastrocytoma
1059. recurrent childhood anaplastic oligodendroglioma
1060. recurrent childhood astrocytoma
1061. recurrent childhood brain stem glioma
1062. recurrent childhood brain tumor
1063. recurrent childhood central nervous system embryonal tumor
1064. recurrent childhood cerebellar astrocytoma
1065. recurrent childhood cerebral astrocytoma
1066. recurrent childhood diffuse astrocytoma
1067. recurrent childhood ependymoma
1068. recurrent childhood fibrillary astrocytoma
1069. recurrent childhood gemistocytic astrocytoma
1070. recurrent childhood giant cell glioblastoma
1071. recurrent childhood glioblastoma
1072. recurrent childhood gliomatosis cerebri
1073. recurrent childhood gliosarcoma
1074. recurrent childhood grade iii lymphomatoid granulomatosis
1075. recurrent childhood large cell lymphoma
1076. recurrent childhood liver cancer
1077. recurrent childhood lymphoblastic lymphoma
1078. recurrent childhood malignant germ cell tumor
1079. recurrent childhood medulloblastoma
1080. recurrent childhood oligoastrocytoma
1081. recurrent childhood oligodendroglioma
1082. recurrent childhood pilocytic astrocytoma
1083. recurrent childhood pilomyxoid astrocytoma
1084. recurrent childhood pineoblastoma
1085. recurrent childhood pleomorphic xanthoastrocytoma
1086. recurrent childhood protoplasmic astrocytoma
1087. recurrent childhood rhabdomyosarcoma
1088. recurrent childhood small noncleaved cell lymphoma
1089. recurrent childhood soft tissue sarcoma
1090. recurrent childhood spinal cord neoplasm
1091. recurrent childhood subependymal giant cell astrocytoma
1092. recurrent childhood supratentorial primitive neuroectodermal and pineal tumors
1093. recurrent childhood supratentorial primitive neuroectodermal tumor
1094. recurrent childhood visual pathway
1095. recurrent childhood visual pathway and hypothalamic glioma
1096. recurrent childhood visual pathway glioma
1097. recurrent colon cancer
1098. recurrent cutaneous t-cell non-hodgkin lymphoma
1099. recurrent endometrial carcinoma
1100. recurrent esophageal cancer
1101. recurrent esthesioneuroblastoma of the paranasal sinus and nasal cavity
1102. recurrent ewing sarcoma
1103. recurrent ewing sarcoma/peripheral primitive neuroectodermal tumor
1104. recurrent extragonadal germ cell tumor
1105. recurrent extragonadal non-seminomatous germ cell tumor
1106. recurrent extrahepatic bile duct cancer
1107. recurrent gallbladder cancer
1108. recurrent gastric cancer
1109. recurrent gastrointestinal carcinoid tumor
1110. recurrent gestational trophoblastic tumor
1111. recurrent grade 1 follicular lymphoma
1112. recurrent grade 2 follicular lymphoma
1113. recurrent grade 3 follicular lymphoma
1114. recurrent hypopharyngeal cancer
1115. recurrent intraocular melanoma
1116. recurrent inverted papilloma of the paranasal sinus and nasal cavity
1117. recurrent islet cell carcinoma
1118. recurrent kaposi sarcoma
1119. recurrent laryngeal cancer
1120. recurrent lip and oral cavity cancer
1121. recurrent lymphoepithelioma of the nasopharynx
1122. recurrent lymphoepithelioma of the oropharynx
1123. recurrent malignant mesothelioma
1124. recurrent malignant testicular germ cell tumor
1125. recurrent mantle cell lymphoma
1126. recurrent marginal zone lymphoma
1127. recurrent melanoma
1128. recurrent metastatic squamous neck cancer with occult primary
1129. recurrent midline lethal granuloma of the paranasal sinus and nasal cavity
1130. recurrent mucoepidermoid carcinoma of the oral cavity
1131. recurrent mycosis fungoides/sezary syndrome
1132. recurrent nasopharyngeal cancer
1133. recurrent neuroblastoma
1134. recurrent neuroendocrine carcinoma of the skin
1135. recurrent non-small cell lung cancer
1136. recurrent oropharyngeal cancer
1137. recurrent osteosarcoma
1138. recurrent ovarian epithelial cancer
1139. recurrent ovarian germ cell tumor
1140. recurrent pancreatic cancer
1141. recurrent paranasal sinus and nasal cavity cancer
1142. recurrent parathyroid cancer
1143. recurrent penile cancer
1144. recurrent pheochromocytoma
1145. recurrent pituitary tumor
1146. recurrent prostate cancer
1147. recurrent rectal cancer
1148. recurrent renal cell cancer
1149. recurrent retinoblastoma
1150. recurrent salivary gland cancer
1151. recurrent small cell lung cancer
1152. recurrent small intestine cancer
1153. recurrent small lymphocytic lymphoma
1154. recurrent solid tumor
1155. recurrent squamous cell carcinoma of the hypopharynx
1156. recurrent squamous cell carcinoma of the larynx
1157. recurrent squamous cell carcinoma of the lip and oral cavity
1158. recurrent squamous cell carcinoma of the nasopharynx
1159. recurrent squamous cell carcinoma of the oropharynx
1160. recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity
1161. recurrent thymoma and thymic carcinoma
1162. recurrent thyroid cancer
1163. recurrent transitional cell cancer of the renal pelvis and ureter
1164. recurrent tumors
1165. recurrent tumors of the ewing's family
1166. recurrent urethral cancer
1167. recurrent uterine sarcoma
1168. recurrent vaginal cancer
1169. recurrent verrucous carcinoma of the larynx
1170. recurrent verrucous carcinoma of the oral cavity
1171. recurrent vulvar cancer
1172. recurrent wilms tumor
1173. recurrent wilms tumor and other childhood kidney tumors
1174. recurrent wilms' tumor
1175. recurrent/refractory childhood hodgkin lymphoma
1176. refractive
1177. refractory
1178. refractory chronic lymphocytic leukemia
1179. refractory hairy cell leukemia
1180. refractory multiple myeloma
1181. refractory pediatric solid tumors
1182. regional gastrointestinal carcinoid tumor
1183. regional neuroblastoma
1184. regional pheochromocytoma
1185. regional transitional cell cancer of the renal pelvis and ureter
1186. registries
1187. relapse
1188. relapsed pediatric solid tumors
1189. relapsed sarcoma
1190. relapsed solid tumor
1191. relapsed/refractory solid tumors
1192. relapsing chronic myelogenous leukemia
1193. renal
1194. renal cancer
1195. renal cell
1196. renal cell cancer
1197. renal cell cancer (rcc)
1198. renal cell carcinoma
1199. renal cell carcinoma (clear cell or non-clear cell)
1200. renal cell carcinoma (rcc)
1201. renal cell carcinoma; phase i; phase ii; immunotherapy
1202. renal failure
1203. renal medullary carcinoma
1204. renal neoplasms
1205. renal pelvis
1206. renal tumor
1207. renal tumors
1208. requiring il-2 treatment
1209. resected
1210. response rate
1211. retina
1212. retinoid
1213. retroperitoneal subsites
1214. retroperitoneal tumor
1215. retroperitoneum
1216. rhabdoid tumor
1217. rhabdoid tumor of the kidney
1218. rhabdomyosarcoma
1219. rhabdomyosarcoma of mediastinum
1220. rhumab-vegf
1221. rhuph20
1222. rmc
1223. ro6874281
1224. sabr
1225. safety
1226. salivary gland acinic cell tumor
1227. salivary gland adenocarcinoma
1228. salivary gland adenoid cystic carcinoma
1229. salivary gland anaplastic carcinoma
1230. salivary gland cancer
1231. salivary gland cancers
1232. salivary gland malignant mixed cell type tumor
1233. salivary gland poorly differentiated carcinoma
1234. salivary gland squamous cell carcinoma
1235. sarcoma
1236. sarcomas
1237. sarcomatoid
1238. sarcomatoid carcinoma of the kidney
1239. sarcomatoid renal cell carcinoma
1240. savolitinib
1241. sbrt
1242. sbrt for children
1243. sclc
1244. sdhb
1245. secondary acute myeloid leukemia
1246. secondary mds
1247. secondary myelodysplastic syndromes
1248. serous epithelial ovarian cancer
1249. sertoli-leydig cell tumor
1250. signet ring adenocarcinoma of the colon
1251. signet ring adenocarcinoma of the rectum
1252. sirolimus
1253. skin metastases
1254. skin pain
1255. small cell lung cancer
1256. small cell neuroendocrine carcinoma of the prostate
1257. small intestine adenocarcinoma
1258. small intestine leiomyosarcoma
1259. small intestine lymphoma
1260. small solid renal tumors
1261. soft tissue sarcoma
1262. solid tumor
1263. solid tumors
1264. somatostatinoma
1265. sorafenib
1266. soy
1267. spartalizumab
1268. spinal cord
1269. splenic marginal zone lymphoma
1270. sporadic papillary renal cell carcinoma;
1271. srf388
1272. stage 0 anal cancer
1273. stage 0 chronic lymphocytic leukemia
1274. stage 0 esophageal cancer
1275. stage 0 melanoma
1276. stage 0 penile cancer
1277. stage 0 rectal cancer
1278. stage 0 vaginal cancer
1279. stage 0 vulvar cancer
1280. stage 4s neuroblastoma
1281. stage i adenoid cystic carcinoma of the oral cavity
1282. stage i adrenocortical carcinoma
1283. stage i adult burkitt lymphoma
1284. stage i adult diffuse large cell lymphoma
1285. stage i adult diffuse mixed cell lymphoma
1286. stage i adult diffuse small cleaved cell lymphoma
1287. stage i adult hodgkin lymphoma
1288. stage i adult immunoblastic large cell lymphoma
1289. stage i adult lymphoblastic lymphoma
1290. stage i adult soft tissue sarcoma
1291. stage i adult t-cell leukemia/lymphoma
1292. stage i anal cancer
1293. stage i basal cell carcinoma of the lip
1294. stage i bladder cancer
1295. stage i childhood anaplastic large cell lymphoma
1296. stage i childhood hodgkin lymphoma
1297. stage i childhood large cell lymphoma
1298. stage i childhood lymphoblastic lymphoma
1299. stage i childhood small noncleaved cell lymphoma
1300. stage i chronic lymphocytic leukemia
1301. stage i cll
1302. stage i colon cancer
1303. stage i cutaneous t-cell non-hodgkin lymphoma
1304. stage i endometrial carcinoma
1305. stage i esophageal cancer
1306. stage i esthesioneuroblastoma of the paranasal sinus and nasal cavity
1307. stage i gastric cancer
1308. stage i grade 1 follicular lymphoma
1309. stage i grade 2 follicular lymphoma
1310. stage i grade 3 follicular lymphoma
1311. stage i inverted papilloma of the paranasal sinus and nasal cavity
1312. stage i lymphoepithelioma of the nasopharynx
1313. stage i lymphoepithelioma of the oropharynx
1314. stage i malignant testicular germ cell tumor
1315. stage i mantle cell lymphoma
1316. stage i marginal zone lymphoma
1317. stage i melanoma
1318. stage i midline lethal granuloma of the paranasal sinus and nasal cavity
1319. stage i mucoepidermoid carcinoma of the oral cavity
1320. stage i multiple myeloma
1321. stage i mycosis fungoides/sezary syndrome
1322. stage i non-small cell lung cancer
1323. stage i ovarian epithelial cancer
1324. stage i ovarian germ cell tumor
1325. stage i pancreatic cancer
1326. stage i penile cancer
1327. stage i prostate cancer
1328. stage i rectal cancer
1329. stage i renal cell cancer
1330. stage i salivary gland cancer
1331. stage i small lymphocytic lymphoma
1332. stage i squamous cell carcinoma of the hypopharynx
1333. stage i squamous cell carcinoma of the larynx
1334. stage i squamous cell carcinoma of the lip and oral cavity
1335. stage i squamous cell carcinoma of the nasopharynx
1336. stage i squamous cell carcinoma of the oropharynx
1337. stage i squamous cell carcinoma of the paranasal sinus and nasal cavity
1338. stage i thymoma
1339. stage i uterine sarcoma
1340. stage i vaginal cancer
1341. stage i verrucous carcinoma of the larynx
1342. stage i verrucous carcinoma of the oral cavity
1343. stage i vulvar cancer
1344. stage i wilms tumor
1345. stage ia cervical cancer
1346. stage ia melanoma
1347. stage ib cervical cancer
1348. stage ib melanoma
1349. stage ii adenoid cystic carcinoma of the oral cavity
1350. stage ii adrenocortical carcinoma
1351. stage ii adult burkitt lymphoma
1352. stage ii adult hodgkin lymphoma
1353. stage ii adult lymphoblastic lymphoma
1354. stage ii adult soft tissue sarcoma
1355. stage ii adult t-cell leukemia/lymphoma
1356. stage ii anal cancer
1357. stage ii basal cell carcinoma of the lip
1358. stage ii bladder cancer
1359. stage ii breast cancer
1360. stage ii childhood anaplastic large cell lymphoma
1361. stage ii childhood hodgkin lymphoma
1362. stage ii childhood large cell lymphoma
1363. stage ii childhood lymphoblastic lymphoma
1364. stage ii childhood small noncleaved cell lymphoma
1365. stage ii chronic lymphocytic leukemia
1366. stage ii cll
1367. stage ii colon cancer
1368. stage ii cutaneous t-cell non-hodgkin lymphoma
1369. stage ii endometrial carcinoma
1370. stage ii esophageal cancer
1371. stage ii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1372. stage ii gastric cancer
1373. stage ii inverted papilloma of the paranasal sinus and nasal cavity
1374. stage ii lymphoepithelioma of the nasopharynx
1375. stage ii lymphoepithelioma of the oropharynx
1376. stage ii malignant testicular germ cell tumor
1377. stage ii melanoma
1378. stage ii midline lethal granuloma of the paranasal sinus and nasal cavity
1379. stage ii mucoepidermoid carcinoma of the oral cavity
1380. stage ii multiple myeloma
1381. stage ii mycosis fungoides/sezary syndrome
1382. stage ii non-small cell lung cancer
1383. stage ii ovarian epithelial cancer
1384. stage ii ovarian germ cell tumor
1385. stage ii pancreatic cancer
1386. stage ii penile cancer
1387. stage ii rectal cancer
1388. stage ii renal cell cancer
1389. stage ii salivary gland cancer
1390. stage ii squamous cell carcinoma of the hypopharynx
1391. stage ii squamous cell carcinoma of the larynx
1392. stage ii squamous cell carcinoma of the lip and oral cavity
1393. stage ii squamous cell carcinoma of the nasopharynx
1394. stage ii squamous cell carcinoma of the oropharynx
1395. stage ii squamous cell carcinoma of the paranasal sinus and nasal cavity
1396. stage ii thymoma
1397. stage ii uterine sarcoma
1398. stage ii vaginal cancer
1399. stage ii verrucous carcinoma of the larynx
1400. stage ii verrucous carcinoma of the oral cavity
1401. stage ii vulvar cancer
1402. stage ii wilms tumor
1403. stage iia cervical cancer
1404. stage iia melanoma
1405. stage iia ovarian epithelial cancer
1406. stage iia ovarian germ cell tumor
1407. stage iia prostate cancer
1408. stage iib cervical cancer
1409. stage iib melanoma
1410. stage iib ovarian epithelial cancer
1411. stage iib ovarian germ cell tumor
1412. stage iib prostate cancer
1413. stage iic melanoma
1414. stage iic ovarian epithelial cancer
1415. stage iic ovarian germ cell tumor
1416. stage iii adenoid cystic carcinoma of the oral cavity
1417. stage iii adrenocortical carcinoma
1418. stage iii adult burkitt lymphoma
1419. stage iii adult diffuse large cell lymphoma
1420. stage iii adult diffuse mixed cell lymphoma
1421. stage iii adult diffuse small cleaved cell lymphoma
1422. stage iii adult hodgkin lymphoma
1423. stage iii adult immunoblastic large cell lymphoma
1424. stage iii adult lymphoblastic lymphoma
1425. stage iii adult soft tissue sarcoma
1426. stage iii adult t-cell leukemia/lymphoma
1427. stage iii basal cell carcinoma of the lip
1428. stage iii bladder cancer
1429. stage iii breast cancer
1430. stage iii cervical cancer
1431. stage iii childhood anaplastic large cell lymphoma
1432. stage iii childhood hodgkin lymphoma
1433. stage iii childhood large cell lymphoma
1434. stage iii childhood liver cancer
1435. stage iii childhood lymphoblastic lymphoma
1436. stage iii childhood small noncleaved cell lymphoma
1437. stage iii chronic lymphocytic leukemia
1438. stage iii cll
1439. stage iii colon cancer
1440. stage iii cutaneous t-cell non-hodgkin lymphoma
1441. stage iii endometrial carcinoma
1442. stage iii esophageal cancer
1443. stage iii esthesioneuroblastoma of the paranasal sinus and nasal cavity
1444. stage iii extragonadal non-seminomatous germ cell tumor
1445. stage iii follicular thyroid cancer
1446. stage iii gastric cancer
1447. stage iii grade 1 follicular lymphoma
1448. stage iii grade 2 follicular lymphoma
1449. stage iii grade 3 follicular lymphoma
1450. stage iii hypopharyngeal cancer
1451. stage iii inverted papilloma of the paranasal sinus and nasal cavity
1452. stage iii laryngeal cancer
1453. stage iii lip and oral cavity cancer
1454. stage iii lymphoepithelioma of the nasopharynx
1455. stage iii lymphoepithelioma of the oropharynx
1456. stage iii malignant testicular germ cell tumor
1457. stage iii mantle cell lymphoma
1458. stage iii marginal zone lymphoma
1459. stage iii melanoma
1460. stage iii midline lethal granuloma of the paranasal sinus and nasal cavity
1461. stage iii mucoepidermoid carcinoma of the oral cavity
1462. stage iii multiple myeloma
1463. stage iii mycosis fungoides/sezary syndrome
1464. stage iii nasopharyngeal cancer
1465. stage iii neuroendocrine carcinoma of the skin
1466. stage iii oropharyngeal cancer
1467. stage iii ovarian epithelial cancer
1468. stage iii ovarian germ cell tumor
1469. stage iii pancreatic cancer
1470. stage iii papillary thyroid cancer
1471. stage iii paranasal sinus and nasal cavity cancer
1472. stage iii penile cancer
1473. stage iii prostate cancer
1474. stage iii rectal cancer
1475. stage iii renal cell cancer
1476. stage iii salivary gland cancer
1477. stage iii small lymphocytic lymphoma
1478. stage iii squamous cell carcinoma of the hypopharynx
1479. stage iii squamous cell carcinoma of the larynx
1480. stage iii squamous cell carcinoma of the lip and oral cavity
1481. stage iii squamous cell carcinoma of the nasopharynx
1482. stage iii squamous cell carcinoma of the oropharynx
1483. stage iii squamous cell carcinoma of the paranasal sinus and nasal cavity
1484. stage iii thymoma
1485. stage iii uterine sarcoma
1486. stage iii vaginal cancer
1487. stage iii verrucous carcinoma of the larynx
1488. stage iii verrucous carcinoma of the oral cavity
1489. stage iii vulvar cancer
1490. stage iii wilms tumor
1491. stage iiia anal cancer
1492. stage iiia breast cancer
1493. stage iiia melanoma
1494. stage iiia non-small cell lung cancer
1495. stage iiia ovarian epithelial cancer
1496. stage iiia ovarian germ cell tumor
1497. stage iiib anal cancer
1498. stage iiib breast cancer
1499. stage iiib melanoma
1500. stage iiib non-small cell lung cancer
1501. stage iiib ovarian epithelial cancer
1502. stage iiib ovarian germ cell tumor
1503. stage iiic breast cancer
1504. stage iiic melanoma
1505. stage iiic ovarian epithelial cancer
1506. stage iiic ovarian germ cell tumor
1507. stage iv adenoid cystic carcinoma of the oral cavity
1508. stage iv adrenocortical carcinoma
1509. stage iv adult burkitt lymphoma
1510. stage iv adult diffuse large cell lymphoma
1511. stage iv adult diffuse mixed cell lymphoma
1512. stage iv adult diffuse small cleaved cell lymphoma
1513. stage iv adult hodgkin lymphoma
1514. stage iv adult immunoblastic large cell lymphoma
1515. stage iv adult lymphoblastic lymphoma
1516. stage iv adult soft tissue sarcoma
1517. stage iv adult t-cell leukemia/lymphoma
1518. stage iv anal cancer
1519. stage iv basal cell carcinoma of the lip
1520. stage iv bladder cancer
1521. stage iv borderline ovarian surface epithelial-stromal tumor
1522. stage iv breast cancer
1523. stage iv childhood anaplastic large cell lymphoma
1524. stage iv childhood hodgkin lymphoma
1525. stage iv childhood large cell lymphoma
1526. stage iv childhood liver cancer
1527. stage iv childhood lymphoblastic lymphoma
1528. stage iv childhood small noncleaved cell lymphoma
1529. stage iv chronic lymphocytic leukemia
1530. stage iv cll
1531. stage iv colon cancer
1532. stage iv cutaneous t-cell non-hodgkin lymphoma
1533. stage iv endometrial carcinoma
1534. stage iv esophageal cancer
1535. stage iv esthesioneuroblastoma of the paranasal sinus and nasal cavity
1536. stage iv extragonadal non-seminomatous germ cell tumor
1537. stage iv follicular thyroid cancer
1538. stage iv gastric cancer
1539. stage iv grade 1 follicular lymphoma
1540. stage iv grade 2 follicular lymphoma
1541. stage iv grade 3 follicular lymphoma
1542. stage iv hypopharyngeal cancer
1543. stage iv inverted papilloma of the paranasal sinus and nasal cavity
1544. stage iv laryngeal cancer
1545. stage iv lip and oral cavity cancer
1546. stage iv lymphoepithelioma of the nasopharynx
1547. stage iv lymphoepithelioma of the oropharynx
1548. stage iv mantle cell lymphoma
1549. stage iv marginal zone lymphoma
1550. stage iv melanoma
1551. stage iv midline lethal granuloma of the paranasal sinus and nasal cavity
1552. stage iv mucoepidermoid carcinoma of the oral cavity
1553. stage iv mycosis fungoides/sezary syndrome
1554. stage iv nasopharyngeal cancer
1555. stage iv non-small cell lung cancer
1556. stage iv oropharyngeal cancer
1557. stage iv ovarian epithelial cancer
1558. stage iv ovarian germ cell tumor
1559. stage iv pancreatic cancer
1560. stage iv papillary thyroid cancer
1561. stage iv paranasal sinus and nasal cavity cancer
1562. stage iv penile cancer
1563. stage iv prostate cancer
1564. stage iv rectal cancer
1565. stage iv renal cell cancer
1566. stage iv salivary gland cancer
1567. stage iv small lymphocytic lymphoma
1568. stage iv squamous cell carcinoma of the hypopharynx
1569. stage iv squamous cell carcinoma of the larynx
1570. stage iv squamous cell carcinoma of the lip and oral cavity
1571. stage iv squamous cell carcinoma of the nasopharynx
1572. stage iv squamous cell carcinoma of the oropharynx
1573. stage iv squamous cell carcinoma of the paranasal sinus and nasal cavity
1574. stage iv uterine sarcoma
1575. stage iv verrucous carcinoma of the larynx
1576. stage iv verrucous carcinoma of the oral cavity
1577. stage iv vulvar cancer
1578. stage iv wilms tumor
1579. stage iva cervical cancer
1580. stage iva thymoma
1581. stage iva vaginal cancer
1582. stage ivb cervical cancer
1583. stage ivb thymoma
1584. stage ivb vaginal cancer
1585. stage ivb vulvar cancer
1586. stage v wilms tumor
1587. stage/type; childhood brain tumor
1588. stage; childhood extracranial germ cell tumor
1589. stage; childhood liver cancer
1590. stage; childhood medulloblastoma
1591. stage; childhood rhabdomyosarcoma
1592. stage; childhood soft tissue sarcoma
1593. stage; ewing's family of tumors
1594. stage; neuroblastoma
1595. stage; osteosarcoma
1596. stage; renal cell cancer
1597. stage; wilms' tumor
1598. stereotactic body radiation therapy
1599. stereotactic body radiotherapy
1600. stickler syndrome
1601. stomach
1602. stromal predominant wilms tumor
1603. su011248
1604. subcutaneous
1605. succinate dehydrogenase (sdh) deficiency
1606. sunitinib
1607. sunitinib malate
1608. suo11248
1609. surgery
1610. surgical navigation
1611. sutent
1612. t-cell large granular lymphocyte leukemia
1613. talazoparib
1614. taminadenant
1615. tarceva
1616. tdt negative childhood acute lymphoblastic leukemia
1617. tdt positive childhood acute lymphoblastic leukemia
1618. telangiectatic osteosarcoma
1619. temsirolimus
1620. temsirolimus resistance
1621. teratoma
1622. testicular choriocarcinoma
1623. testicular choriocarcinoma and embryonal carcinoma
1624. testicular choriocarcinoma and seminoma
1625. testicular choriocarcinoma and teratoma
1626. testicular choriocarcinoma and yolk sac tumor
1627. testicular embryonal carcinoma
1628. testicular embryonal carcinoma and seminoma
1629. testicular embryonal carcinoma and teratoma
1630. testicular embryonal carcinoma and teratoma with seminoma
1631. testicular embryonal carcinoma and yolk sac tumor
1632. testicular embryonal carcinoma and yolk sac tumor with seminoma
1633. testicular teratoma
1634. testicular yolk sac tumor
1635. testicular yolk sac tumor and teratoma
1636. testicular yolk sac tumor and teratoma with seminoma
1637. th2 cells
1638. thermodox
1639. thrombocytopenia
1640. thromboembolism
1641. thrombus
1642. thymus cancer
1643. thyroid gland medullary carcinoma
1644. tivozanib
1645. tolerability
1646. tongue cancer
1647. toripalimab
1648. toxicity
1649. transitional care planning
1650. transitional cell cancer of the renal pelvis and ureter
1651. transitional cell carcinoma
1652. transitional cell carcinoma of the bladder
1653. translocation carcinoma
1654. translocation renal cell carcinoma
1655. treatment experienced
1656. triple negative breast cancer
1657. trk expression
1658. troponin
1659. tumor
1660. tumor development
1661. tumor marker
1662. tumor purging
1663. tumors
1664. tumors metastatic to brain
1665. tumour
1666. type 1 papillary renal cell carcinoma
1667. type 2 papillary renal cell carcinoma
1668. tyrosine kinase inhibitor
1669. tyrosine kinase inhibitor failure
1670. uc
1671. ultrasound-guided biopsy
1672. unclassified renal cell carcinoma
1673. uncommon disease
1674. undiagnosed
1675. undifferentiated carcinoma of unknown primary
1676. unresectable advanced
1677. unresectable advanced renal cell carcinoma
1678. unresectable and/or metastatic renal cell cancer
1679. unresectable extrahepatic bile duct cancer
1680. unresectable gallbladder cancer
1681. unresectable neuroblastoma
1682. unresectable rcc
1683. unresectable renal cell carcinoma
1684. unspecified adult solid tumor; protocol specific
1685. unspecified childhood solid tumor
1686. unspecified childhood solid tumor; protocol specific
1687. untreated adult acute lymphoblastic leukemia
1688. untreated adult acute myeloid leukemia
1689. untreated childhood acute lymphoblastic leukemia
1690. untreated childhood acute myeloid leukemia
1691. untreated childhood acute myeloid leukemia and other myeloid malignancies
1692. untreated childhood anaplastic astrocytoma
1693. untreated childhood anaplastic oligoastrocytoma
1694. untreated childhood anaplastic oligodendroglioma
1695. untreated childhood brain stem glioma
1696. untreated childhood cerebellar astrocytoma
1697. untreated childhood cerebral astrocytoma
1698. untreated childhood diffuse astrocytoma
1699. untreated childhood fibrillary astrocytoma
1700. untreated childhood gemistocytic astrocytoma
1701. untreated childhood giant cell glioblastoma
1702. untreated childhood glioblastoma
1703. untreated childhood gliomatosis cerebri
1704. untreated childhood gliosarcoma
1705. untreated childhood medulloblastoma
1706. untreated childhood oligoastrocytoma
1707. untreated childhood oligodendroglioma
1708. untreated childhood pilocytic astrocytoma
1709. untreated childhood pilomyxoid astrocytoma
1710. untreated childhood pleomorphic xanthoastrocytoma
1711. untreated childhood protoplasmic astrocytoma
1712. untreated childhood subependymal giant cell astrocytoma
1713. untreated childhood supratentorial primitive neuroectodermal tumor
1714. untreated childhood visual pathway
1715. untreated childhood visual pathway and hypothalamic glioma
1716. untreated childhood visual pathway glioma
1717. untreated hairy cell leukemia
1718. untreated metastatic squamous neck cancer with occult primary
1719. ureter
1720. urethra
1721. urethral cancer associated with invasive bladder cancer
1722. urogenital abnormalities
1723. urothelial cancer
1724. urothelial carcinoma
1725. uterine carcinosarcoma
1726. uterine fibroid
1727. uterine leiomyosarcoma
1728. vaccine
1729. vaccine therapy
1730. vaccinia virus
1731. vaginal adenocarcinoma
1732. vaginal clear cell adenocarcinoma
1733. vascular endothelial growth factor
1734. vascular endothelial growth factor (vegf)
1735. vascular endothelial growth factor receptor 2 (vegfr2)
1736. vegf
1737. vegf inhibitor
1738. vegf pathway
1739. vegf trap
1740. vegfr inhibitor
1741. vegfr tki
1742. vestibular function
1743. vhl
1744. vhl disease
1745. vhl gene
1746. vhl germline mutation
1747. vhl somatic mutation
1748. vhl syndrome
1749. vincristine sulfate
1750. von hippel lindau
1751. von hippel lindau (vhl)
1752. von hippel lindau disease
1753. von hippel-lindau disease
1754. von hippel-lindau gene
1755. von hippel-lindau syndrome
1756. vulvar cancer
1757. wagr syndrome
1758. waldenström macroglobulinemia
1759. waldenstrom macroglobulinemia
1760. wdha syndrome
1761. weight changes
1762. wiedermann-steiner syndrome
1763. wilm's tumor
1764. wilms
1765. wilms tumor
1766. wilms tumor 1
1767. wilms tumor and other childhood kidney tumors
1768. wilms tumor protein 1
1769. wilms tumour
1770. wilms' tumor
1771. wilms' tumor 1
1772. wt1
1773. xeloda
1774. xl-184
1775. xl184
1776. young adults
1777. zirconium-89
Phase
Overall_status
Official_title
Search:
Intervention
Search:
0.
1. 13c-acetate
2. 13c-fructose
3. 13c-glucose
4. 13c-glutamine
5. 13c-lactate
6. 17 allylamino-17-demethoxygeldanamycin
7. 18 fdg (fludeoxyglucose 18f)
8. 3-dimensional conformal radiation therapy
9. 89zr bevacizumab pet scan
10. 89zr-df-crefmirlimab
11. 99mtc-sestamibi imaging
12. [15-o] h2o
13. a166
14. abbv-176
15. abdominal surgery
16. abemaciclib
17. abi-007/carboplatin/trastuzumab
18. abr-217620/naptumomab estafenatox
19. abt-751
20. active comparator
21. acyclovir
22. acyclovir sodium
23. adgmcaix-transduced autologous dendritic cells
24. adjuvant therapy
25. agar t cells
26. ags-16c3f
27. ags-16m18
28. ags-16m8f
29. aldesleukin
30. alectinib
31. alemtuzumab
32. alisertib
33. allele-specific oligonucleotide real-time quantitative polymerase chain reaction
34. allogeneic bone marrow transplantation
35. allogeneic hematopoietic stem cell transplant (hsct)
36. alvocidib
37. amifostine trihydrate
38. anti-endoglin chimeric monoclonal antibody trc105
39. anti-seizure prophylaxis
40. anti-thymocyte globulin
41. arq 197
42. arsenic trioxide
43. as1409
44. as1411
45. assessment of therapy complications
46. atezolizumab
47. atezolizumab (mpdl3280a); an engineered anti-pd-l1 antibody
48. autogene cevumeran
49. autologous bone marrow transplantation
50. autologous dendritic cell vaccination
51. autologous hematopoietic stem cell transplantation
52. autologous stem cell infusion
53. avastin (bevacizumab)
54. avelumab
55. axitinib
56. axitinib oral tablet [inlyta]
57. azd6094
58. b7-h3 car t cells
59. bbi503
60. beclomethasone dipropionate
61. belzutifan
62. bempegaldesleukin
63. best practice
64. bevacizumab
65. biological : toripalimab drug: axitinib
66. biopsy
67. biospecimen collection
68. bkm-120 bevacizumab
69. blood draws
70. blood pressure measurement
71. blood specimen
72. bms-247550
73. bnc105p
74. bone marrow ablation with stem cell support
75. bortezomib
76. botulinum toxin type a
77. busulfan
78. busulfan; melphalan
79. cabometyx
80. cabozantinib
81. cabozantinib s-malate
82. cabozantinib tablets
83. capecitabine
84. captopril
85. carboplatin
86. care t cells
87. caspofungin acetate
88. cci-779
89. cdx-014
90. chpp of cisplatin
91. cisplatin
92. cixutumumab
93. clinical management
94. clinimacs
95. clofarabine
96. cngrc peptide-tnf alpha conjugate
97. combination therapy: py314 + pembrolizumab
98. complete surgical resection
99. conservative surgery
100. conventional surgery
101. counseling intervention
102. cpg 7909
103. crizotinib
104. crizotinib (pf-02341066)
105. cryosurgery
106. cyclophosphamide
107. cyclosporine
108. cyproheptadine hydrochloride
109. cytogenetic analysis
110. cytology specimen collection procedure
111. cytomegalovirus ie-1-specific cytotoxic t lymphocytes
112. cytomegalovirus pp65-specific cytotoxic t lymphocytes
113. cytoreductive nephrectomy
114. cytoxan
115. dactinomycin
116. dalteparin
117. dasatinib
118. dd-4a chemotherapy regimen
119. dehydrated human amnion/chorion membrane
120. dexamethasone
121. dff332
122. diagnostic laboratory biomarker analysis
123. diphenhydramine
124. dna analysis
125. dna methylation analysis
126. docetaxel
127. donor hematopoietic stem cell harvest
128. donor lymphocyte harvest
129. dovitinib
130. doxil
131. doxorubicin
132. doxorubicin hcl liposome
133. doxorubicin hydrochloride
134. dsp-7888 dosing emulsion
135. durvalumab
136. dynamic contrast-enhanced magnetic resonance imaging
137. ec17 (folate-fitc)
138. ec90 (klh-fitc)
139. educational intervention
140. em tracking
141. enhanze (rhuph20)
142. enoblituzumab
143. ensartinib
144. entinostat
145. enzyme-linked immunosorbent assay
146. epacadostat
147. epithelial cell adhesion molecule (epcam) ferrofluid
148. epl diluent
149. epothilone b
150. erdafitinib
151. erlotinib
152. erlotinib hydrochloride
153. esk981
154. etanercept
155. etoposide
156. etoposide phosphate
157. evaluation of cancer risk factors
158. everolimus
159. everolimus (afinitor) tablets
160. everolimus and bevacizumab
161. everolimus and sorafenib
162. fentanyl sublingual spray
163. filgrastim
164. flow cytometry
165. fluconazole
166. fludara
167. fludarabine
168. fludarabine phosphate
169. fluorescence in situ hybridization
170. fluzoparib
171. foretinib (formerly gsk1363089 or xl880)
172. g-csf
173. g-csf (granulocyte-colony stimulating factor)
174. gag score
175. galil medical patented 17g cryoablation needles
176. galinpepimut-s
177. gamma-secretase/notch signalling pathway inhibitor ro4929097
178. gemcitabine
179. gemcitabine hydrochloride
180. gemcitabine; capecitabine and sorafenib (6 cycles)
181. gene expression analysis
182. gene mapping
183. gene rearrangement analysis
184. genistein
185. glutamic acid
186. glutamine
187. gpi-0100
188. graft versus host disease prophylaxis/therapy
189. guided therapy
190. gvhd prophylaxis
191. gw786034
192. hc-5404-fu
193. heparin
194. hkt288
195. hsv1716
196. ifn-alpha
197. ifn-alpha with retinoic acid
198. ifosfamide
199. il-2
200. imatinib mesylate
201. immune cell and ctc detection procedures
202. immunohistochemistry staining method
203. immunologic technique
204. immunological diagnostic method
205. in vitro-treated bone marrow transplantation
206. inc280
207. incb050465
208. incb099318
209. incomplete freund's adjuvant
210. indinavir sulfate
211. indium in 111 pentetreotide
212. indocyanine green
213. induction therapy
214. infection prophylaxis and management
215. intensity-modulated radiation therapy
216. interferon
217. interferon alpha-2a
218. interferon-alpha
219. interleukin-2
220. ipilimumab
221. ipilimumab placebo
222. ipilimumab plus nivolumab
223. irinotecan
224. irinotecan hydrochloride
225. itacitinib
226. itraconazole
227. ivosidenib
228. ixabepilone
229. ixazomib
230. ixazomib citrate
231. jnj-78306358
232. laboratory biomarker analysis
233. larotrectinib
234. larotrectinib sulfate
235. lenvatinib
236. leukapheresis
237. liposomal amphotericin b
238. liposomal vincristine
239. liposomal vincristine sulfate
240. liquid chromatography
241. lithium carbonate
242. lorvotuzumab mertansine
243. loss of heterozygosity analysis
244. lyso-thermosensitive liposomal doxorubicin
245. magnetic resonance high intensity focused ultrasound
246. magnetic resonance-guided high intensity focused ultrasound
247. management of therapy complications
248. marqibo
249. mass spectrometry
250. medi4736
251. medical chart review
252. medication (a specification is listed under each arm)
253. melphalan
254. mesenchymal-marker based ferrofluid (c-met)
255. mesna
256. metformin
257. methotrexate
258. methylprednisolone
259. metronomic cyclophosphamide
260. microarray analysis
261. microwave ablation (mwa)
262. minocycline-edta
263. mk-6482
264. molecular genetic technique
265. monoclonal antibody rav12
266. mri dwi sequence (adc values)
267. multiparametric mr imaging (mpmri)
268. music therapy (books on tape)
269. music video
270. mutation analysis
271. mutation carrier screening
272. mycophenolate mofetil
273. myeloablative chemotherapy
274. myeloid growth factor
275. neoadjuvant therapy
276. neoantigen dna vaccine
277. nephrectomy
278. neulasta
279. nexavar (sorafenib; bay43-9006)
280. nir178
281. nivolumab
282. nivolumab and rhuph20
283. nivolumab placebo
284. nonmyeloablative allogeneic hematopoietic stem cell transplantation
285. nonmyeloablative allogeneic hsct
286. nucleic acid amplification
287. nucleic acid sequencing
288. nutritional intervention
289. o6-benzylguanine
290. oblimersen sodium
291. observational
292. odsh
293. olaparib
294. oleclumab
295. onivyde
296. osi-774
297. oxaliplatin
298. p53; ki67 and cyclin a ihc.
299. paclitaxel
300. paclitaxel albumin-stabilized nanoparticle formulation
301. pain therapy
302. palbociclib
303. palivizumab
304. pamiparib
305. panobinostat
306. panzem® ncd
307. partial nephrectomy
308. partial or radical nephrectomy
309. patient observation
310. patient reported outcomes measurement
311. patients with sunitinib or pazopanib
312. pazopanib
313. pazopanib (gw786034)
314. pazopanib hydrochloride
315. pazopanib+sorafenib
316. pdr001
317. pegylated alfa interferon
318. pembrolizumab
319. pemetrexed
320. pentostatin
321. perflutren lipid microsphere
322. perifosine
323. peripheral blood lymphocyte therapy
324. peripheral blood stem cell transplantation
325. peripheral blood stem cell transplantation (pbsc)
326. pf-06801591
327. pf-06940434
328. pharmacokinetic study
329. pharmacological study
330. placebo
331. placebo (saline solution)
332. placebo administration
333. polymerase chain reaction
334. polymorphism analysis
335. polyvinylpyrrolidone-sodium hyaluronate gel
336. prednisone
337. protein expression analysis
338. proteomic profiling
339. proton beam radiation (pbrt)
340. proton beam radiation using pencil beam scanning
341. psychosocial assessment and care
342. pt2385 tablets
343. py314
344. quality-of-life assessment
345. questionnaire
346. questionnaire administration
347. rad001
348. rad001 and sorafenib
349. radiation
350. radiation therapy
351. radiofrequency
352. radium ra 223 dichloride
353. radium-223
354. ranitidine
355. recombinant human lactoferrin
356. recombinant human thrombopoietin
357. recombinant interferon alfa
358. recombinant interferon alfa-2b
359. recombinant interleukin-11
360. recombinant interleukin-12
361. recombinant vaccinia gm-csf; rac vac gm-csf (jx-594)
362. research blood collection
363. research blood draw
364. resting night splint
365. retifanlimab
366. reverse transcriptase-polymerase chain reaction
367. rhumab vegf (bevacizumab)
368. ribavirin
369. ritonavir
370. rituximab
371. rna analysis
372. ro4929097
373. ro6874281
374. sacituzumab govitecan-hziy (sg)
375. samotolisib
376. sargramostim
377. savolitinib
378. second generation 4-1bbζ b7h3-egfrt-dhfr
379. second generation 4-1bbζ b7h3-egfrt-dhfr(selected) and a second generation 4-1bbζ cd19-her2tg
380. second generation 4-1bbζ egfr806-egfrt
381. second generation 4-1bbζ egfr806-egfrt and a second generation 4 1bbζ cd19-her2tg
382. selpercatinib
383. selumetinib sulfate
384. seneca valley virus-001
385. sgi-110 (guadecitabine)
386. shark cartilage extract ae-941
387. simvastatin
388. sirolimus
389. solid ankle foot orthotic
390. sorafenib
391. sorafenib (nexavar; bay43-9006)
392. sorafenib escalated dose
393. sorafenib standard dose
394. sorafenib tosylate
395. sorafenib+pazopanib
396. spectroscopy
397. srf388
398. standard of care
399. stem cell rescue
400. stem cell transplantation
401. stem cells
402. stereotactic ablative radiotherapy
403. stereotactic body radiation therapy
404. stereotactic body radiotherapy (sbrt)
405. su011248
406. sulfur hexafluoride lipid microspheres
407. sunitinib
408. sunitinib (sutent)
409. sunitinib malate
410. sunitinib monotherapy
411. supersaturated calcium phosphate rinse
412. surgery
413. surgical removal of tumor tissue for t cell production
414. surgical resection
415. tacrolimus
416. tak-228
417. talabostat mesylate
418. talazoparib
419. tandutinib
420. tanespimycin
421. tarceva (erlotinib hcl)
422. tariquidar
423. tazemetostat
424. tds-im v1.0 system
425. tegavivint
426. temozolomide
427. temsirolimus
428. th2 rapa cells
429. thalidomide
430. therapeutic allogeneic lymphocytes
431. therapeutic autologous dendritic cells
432. therapeutic autologous lymphocytes
433. therapeutic conventional surgery
434. therapeutic nutritional supplementation
435. thiotepa
436. til infusion
437. tinzaparin sodium
438. tipifarnib
439. tivantinib
440. tivozanib
441. tivozanib (av-951)
442. tivozanib hydrochloride
443. to study the polymorphism of the gene encoding vegf (rs699947) as a predictive marker
444. tomotherapy
445. topotecan
446. topotecan hydrochloride
447. topotecan; filgrastim (g-csf); pegfilgrastim
448. toripalimab
449. total marrow irradiation
450. total-body irradiation
451. trastuzumab
452. traumeel s
453. trebananib
454. tremelimumab
455. trovax
456. trovax® (immunological vaccine therapy)
457. ulixertinib
458. ultrasound imaging
459. ursodiol
460. valacyclovir
461. vandetanib
462. vandetanib/metformin
463. vatalanib
464. vegf trap
465. vemurafenib
466. vincristine
467. vincristine sulfate
468. vinorelbine ditartrate
469. volociximab (anti-α5β1 integrin monoclonal antibody)
470. von hippel-lindau peptide vaccine
471. voriconazole
472. vorinostat
473. western blotting
474. whole lung radiation
475. xl092
476. xmab20717
477. zactima (vandetanib) (zd6474)
478. zirconium-89 girentuximab pet/ct
Facility
Search: